CELC
$56.58-6.17%
Celcuity Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.01%US Stock Market 0.006%Russell 3000 0.005%
CELC — Celcuity Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Volume
20.040.060.080.0100.0120.0140.0020.0M40.0M$56.58—20172020202220242026
2026-10-16
Price$56.58
MA20$86.99
MA50$99.53
Vol10.4M
Key stats#
Price data
- Price
- $56.58
- YTD price return
- -43.27%
- YTD total return
- -43.27%
- Next earnings
- Nov 11, 2026
- Market cap
- 2.8B
- Enterprise value
- 2B
- Shares outstanding
- 48.9M
- 52W low
- $49.80
- 52W high
- $151.02
- From 52W high
- -62.53%
- From 52W low
- +13.61%
- 52W range
- 7%
Volume
- Rel volume
- 3.10×
- 30D volume
- 1.4M
- 30D $ vol
- 101.4M
Fundamentals
- EPS (ttm)
- -$4.32
- FCF (ttm)
- -192.2M
- FCF/share
- -$3.93
- Book value/share
- -$0.26
- ROA
- -27.35%
- Current ratio
- 8.93
Growth (CAGR, ttm) · 10Y
- Shares
- +15.34%+30.35%+26.84%n/a
Per-share growth (CAGR, ttm) · 10Y
- Price
- +7.72%+75.29%+25.45%n/a
- Total return
- +7.72%+75.29%+25.45%n/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -13.1×
- Fwd P/E
- -849.3×
- P/B (mrq)
- -216.6×
- FCF yield (ttm)
- -6.94%
- Buyback yield (realized, 1y)
- -15.34%
- Shareholder yield (realized, 1y)
- -15.34%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 0.00%
Vs own 10Y history
- P/B
- 98th
Bar = where today’s multiple sits in CELC’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-16#
1D
-6.17%
5D
-16.72%
1M
-31.48%
3M
-35.92%
YTD
-43.27%
1Y
+7.71%
5Y
+210.88%
Financial statements
Open full CELC financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +10.48% | +0.43% |
| JNJ | Johnson & Johnson | -4.38% | +0.90% |
| ABBV | AbbVie Inc. | +8.73% | +0.71% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +6.97% | -1.29% |
| MRK | Merck & Co. Inc. | +0.72% | +0.52% |
| NVS | Novartis AG | +8.59% | +0.16% |
| TMO | Thermo Fisher Scientific Inc. | +6.41% | -0.93% |
| AMGN | Amgen Inc. | +14.92% | -0.35% |
